Terms: = Endocrine gland cancer AND CDK6, MGC59692, 1021, Q00534, ENSG00000105810, PLSTIRE AND Prognosis
30 results:
1. Identification of prognostic factors and construction of nomogram to predict cancer-specific survival for patients with ovarian granulosa cell tumors.
Zhang Y; Zhang Z; Ding X; Zhang K; Dai Y; Cheng W; Luo C
Cancer Rep (Hoboken); 2024 Mar; 7(3):e2046. PubMed ID: 38507268
[TBL] [Abstract] [Full Text] [Related]
2. Depletion of
Yoshizawa M; Shiozaki A; Ashihara E
Cancer Genomics Proteomics; 2024; 21(1):18-29. PubMed ID: 38151292
[TBL] [Abstract] [Full Text] [Related]
3. Multifactor assessment of ovarian cancer reveals immunologically interpretable molecular subtypes with distinct prognoses.
Guo Y; Li S; Li C; Wang L; Ning W
Front Immunol; 2023; 14():1326018. PubMed ID: 38143770
[TBL] [Abstract] [Full Text] [Related]
4. SETD2 variation correlates with tumor mutational burden and MSI along with improved response to immunotherapy.
Zheng X; Lin J; Xiong J; Guan Y; Lan B; Li Y; Gao X; Fei Z; Chen L; Chen L; Chen L; Chen G; Guo Z; Yi X; Cao W; Ai X; Zhou C; Li X; Zhao J; Yan X; Yu Q; Si L; Chen Y; Chen C
BMC Cancer; 2023 Jul; 23(1):686. PubMed ID: 37479966
[TBL] [Abstract] [Full Text] [Related]
5. OTUD7B deubiquitinates and stabilizes YAP1 to upregulate NUAK2 expression, thus accelerating gastric cancer procession.
Guo Z; Guo L
Dig Liver Dis; 2024 Feb; 56(2):352-362. PubMed ID: 37429790
[TBL] [Abstract] [Full Text] [Related]
6. Clinical features and therapeutic outcomes of GH/TSH cosecreting pituitary adenomas: experience of a single pituitary center.
Yu N; Duan L; Hu F; Yang S; Liu J; Chen M; Yao Y; Deng K; Feng F; Lian X; Mao X; Zhu H
Front Endocrinol (Lausanne); 2023; 14():1197244. PubMed ID: 37324275
[TBL] [Abstract] [Full Text] [Related]
7. Correlation of DNA methylation and lymph node metastasis in papillary thyroid carcinoma.
Zhao F; Zhu S; Fang J; Dong H; Zhu C
Head Neck; 2023 Jul; 45(7):1654-1662. PubMed ID: 37097909
[TBL] [Abstract] [Full Text] [Related]
8. nc-RNA-mediated high expression of cdk6 correlates with poor prognosis and immune infiltration in pancreatic cancer.
Zhao YX; Xu BW; Wang FQ; Jiang FY; Xu JW; Yu DX
Cancer Med; 2023 Feb; 12(4):5110-5123. PubMed ID: 36457244
[TBL] [Abstract] [Full Text] [Related]
9. lncRNA SNHG15 Promotes Ovarian cancer Progression through Regulated cdk6 via Sponging miR-370-3p.
Wang Y; Ding M; Yuan X; Jiao R; Zhu D; Huang W; Deng W; Liu Y
Biomed Res Int; 2021; 2021():9394563. PubMed ID: 34734088
[TBL] [Abstract] [Full Text] [Related]
10. KDM1A and KDM3A promote tumor growth by upregulating cell cycle-associated genes in pancreatic cancer.
Hou X; Li Q; Yang L; Yang Z; He J; Li Q; Li D
Exp Biol Med (Maywood); 2021 Sep; 246(17):1869-1883. PubMed ID: 34171978
[TBL] [Abstract] [Full Text] [Related]
11. The RNA-binding protein MEX3A is a prognostic factor and regulator of resistance to gemcitabine in pancreatic ductal adenocarcinoma.
Panzeri V; Manni I; Capone A; Naro C; Sacconi A; Di Agostino S; de Latouliere L; Montori A; Pilozzi E; Piaggio G; Capurso G; Sette C
Mol Oncol; 2021 Feb; 15(2):579-595. PubMed ID: 33159833
[TBL] [Abstract] [Full Text] [Related]
12. miR-3613-5p enhances the metastasis of pancreatic cancer by targeting cdk6.
Cao R; Wang K; Long M; Guo M; Sheng L; Zhan M; Yang R; Wang H; Yang L
Cell Cycle; 2020 Nov; 19(22):3086-3095. PubMed ID: 33073681
[TBL] [Abstract] [Full Text] [Related]
13. Knockdown of ribosomal protein S6 suppresses proliferation, migration, and invasion in epithelial ovarian cancer.
Yang X; Xu L; Yang YE; Xiong C; Yu J; Wang Y; Lin Y
J Ovarian Res; 2020 Aug; 13(1):100. PubMed ID: 32862831
[TBL] [Abstract] [Full Text] [Related]
14. Hsa_circ_0009910: oncogenic circular RNA targets microRNA-145 in ovarian cancer cells.
Li Y; Lin S; An N
Cell Cycle; 2020 Aug; 19(15):1857-1868. PubMed ID: 32588730
[TBL] [Abstract] [Full Text] [Related]
15. Outcome according to residual disease (surgeon's report vs pre-chemotherapy imaging) in patients with bevacizumab-treated ovarian cancer: Analysis of the ROSiA study.
Korach J; Colombo N; Mendiola C; Selle F; Dolado I; Donica M; Oza AM
J Surg Oncol; 2019 Sep; 120(4):786-793. PubMed ID: 31368160
[TBL] [Abstract] [Full Text] [Related]
16. Coagulative necrotic pituitary adenoma apoplexy: A retrospective study of 21 cases from a large pituitary center in China.
Wang Z; Gao L; Wang W; Guo X; Feng C; Lian W; Li Y; Xing B
Pituitary; 2019 Feb; 22(1):13-28. PubMed ID: 30390276
[TBL] [Abstract] [Full Text] [Related]
17. Safety and Efficacy of Extended Bevacizumab Therapy in Elderly (≥70 Years) Versus Younger Patients Treated for Newly Diagnosed Ovarian cancer in the International ROSiA Study.
Selle F; Colombo N; Korach J; Mendiola C; Cardona A; Ghazi Y; Oza AM
Int J Gynecol Cancer; 2018 May; 28(4):729-737. PubMed ID: 29498983
[TBL] [Abstract] [Full Text] [Related]
18. A hypothesis-driven approach identifies CDK4 and cdk6 inhibitors as candidate drugs for treatments of adrenocortical carcinomas.
Hadjadj D; Kim SJ; Denecker T; Ben Driss L; Cadoret JC; Maric C; Baldacci G; Fauchereau F
Aging (Albany NY); 2017 Dec; 9(12):2695-2716. PubMed ID: 29283884
[TBL] [Abstract] [Full Text] [Related]
19. The histopathologic type predicts survival of patients with ampullary carcinoma after resection: A meta-analysis.
Zhou Y; Li D; Wu L; Si X
Pancreatology; 2017; 17(2):273-278. PubMed ID: 28131524
[TBL] [Abstract] [Full Text] [Related]
20. Prognostic and therapeutic value of disruptor of telomeric silencing-1-like (DOT1L) expression in patients with ovarian cancer.
Zhang X; Liu D; Li M; Cao C; Wan D; Xi B; Li W; Tan J; Wang J; Wu Z; Ma D; Gao Q
J Hematol Oncol; 2017 Jan; 10(1):29. PubMed ID: 28114995
[TBL] [Abstract] [Full Text] [Related]
[Next]
